380
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Integrated virtual screening and molecular dynamics simulation approaches revealed potential natural inhibitors for DNMT1 as therapeutic solution for triple negative breast cancer

, , , , , , , , & show all
Pages 1099-1109 | Received 25 Oct 2022, Accepted 28 Mar 2023, Published online: 06 Apr 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Nahlah Makki Almansour. Identification of promising inhibitors against breast cancer disease by targeting NUDIX hydrolase 5 (NUDT5) biomolecule. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-12.
Read now
Bandar Aloufi, Fahad M. Alshabrmi, Nagaraja Sreeharsha & Abdur Rehman. Exploring therapeutic targets and drug candidates for obesity: a combined network pharmacology, bioinformatics approach. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-22.
Read now

Articles from other publishers (4)

Yang He, Qin Hu, Liting Wang & Chuanrong Chen. (2024) Decitabine/paclitaxel co-delivery systems modified with anti-PD-L1 antibodies mediate chemoimmunotherapy for Triple negative breast cancer. Materials & Design 237, pages 112562.
Crossref
Diana L. Prado-Romero, Alejandro Gómez-García, Raziel Cedillo-González, Hassan Villegas-Quintero, Juan F. Avellaneda-Tamayo, Edgar López-López, Fernanda I. Saldívar-González, Ana L. Chávez-Hernández & José L. Medina-Franco. (2023) Consensus docking aid to model the activity of an inhibitor of DNA methyltransferase 1 inspired by de novo design. Frontiers in Drug Discovery 3.
Crossref
Faez Falah Alshehri. (2023) Integrated virtual screening, molecular modeling and machine learning approaches revealed potential natural inhibitors for epilepsy. Saudi Pharmaceutical Journal 31:12, pages 101835.
Crossref
Shah Faisal, Muhammad Hamza Tariq, Riaz Ullah, Sania Zafar, Muhammad Rizwan, Nadia bibi, Aishma Khattak, Noora Amir & Abdullah. (2023) Exploring the antibacterial, antidiabetic, and anticancer potential of Mentha arvensis extract through in-silico and in-vitro analysis. BMC Complementary Medicine and Therapies 23:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.